Infinity Pharmaceuticals Price To Sales Ratio Over Time
| INFIQ Stock | 0.0001 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Infinity Pharmaceuticals Performance and Infinity Pharmaceuticals Correlation. Infinity |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuticals. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.029 | Quarterly Revenue Growth (0.15) | Return On Assets (0.61) |
The market value of Infinity Pharmaceuticals is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuticals' market value can be influenced by many factors that don't directly affect Infinity Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Infinity Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare Infinity Pharmaceuticals and related stocks such as Kinetik Holdings, Atmos Energy, and Live Ventures Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KNTK | 39.9244 | 39.9244 | 39.9244 | 39.9244 | 39.9244 | 39.9244 | 39.9244 | 39.9244 | 5.1129 | 2.8538 | 2.1864 | 1.7502 | 1.1275 | 1.3776 | 1.31 |
| ATO | 0.1707 | 2.4047 | 2.7306 | 2.9422 | 3.5286 | 3.1407 | 4.8498 | 3.3048 | 4.5998 | 4.1605 | 3.3592 | 3.3411 | 3.5956 | 5.0789 | 5.33 |
| LIVE | 8.3681 | 3.2745 | 4.5736 | 5.3914 | 0.7937 | 0.4086 | 0.1802 | 0.1668 | 0.0843 | 0.1648 | 0.4314 | 0.2721 | 0.2496 | 0.29 | 0.27 |
| TGS | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 1.7437 | 0.7149 | 0.2588 | 1.235 | 5.1597 | 5.42 |
| AM | 16.2318 | 16.2318 | 16.2318 | 16.2318 | 16.2318 | 16.2318 | 10.6521 | 2.0332 | 2.0332 | 3.9544 | 3.7961 | 19.7302 | 5.2088 | 5.4385 | 9.22 |
| HVT | 0.397 | 0.3293 | 0.5364 | 0.9407 | 0.6481 | 0.5993 | 0.6204 | 0.5862 | 0.4717 | 0.4998 | 0.6897 | 0.5445 | 0.4347 | 0.6172 | 0.36 |
| OGS | 0.9377 | 1.0512 | 1.238 | 1.0107 | 1.1867 | 1.7044 | 2.3506 | 2.4994 | 2.5674 | 2.9947 | 2.6656 | 2.2984 | 1.5921 | 1.4936 | 1.46 |
Infinity Pharmaceuticals and related stocks such as Kinetik Holdings, Atmos Energy, and Live Ventures Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Infinity Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Infinity Pharmaceuticals sales, a figure that is much harder to manipulate than other Infinity Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Infinity Pharmaceuticals | INFIQ |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 1100 Massachusetts Avenue, |
| Exchange | NASDAQ Exchange |
null 1.0E-4
Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.